Cancer cells have been observed to induce expression of Jag1/2 in MDSCs via the NF-Kβ pathway and targeting Jag1/2 in MDSCs by use of a neutralizing antibody was shown to inhibit arginase I, iNOS and decreased tumor growth (Sierra et al., 2017). The gene discussed is JAG1; the disease is neoplasm.